Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Clinical Therapeutics
|
January 1, 1985
Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial
G B Calandra, M Hesney, K R Brown
European Journal of Cancer & Clinical Oncology
|
January 1, 1988
The tolerability profile of prophylactic norfloxacin in neutropenic patients
M L Corrado, W E Struble, M Hesney
European Journal of Clinical Microbiology
|
October 1, 1984
A multiclinic randomized study of the comparative efficacy, safety and tolerance of imipenem/cilastatin and moxalactam
G B Calandra, M Hesney, C Grad
Journal of Pharmaceutical Sciences
|
June 1, 1978
Bioequivalence and interchangeability
S Hwang, P B Huber, M Hesney, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
August 5, 2000
Enalapril in RAPIDISC (wafer formulation): pharmacokinetic evaluation of a novel, convenient formulation
Lo M-W, J B McCrea, C R Shadle, et al.
European Urology
|
January 1, 1990
Norfloxacin versus trimethoprim-sulfamethoxazole in the treatment of urinary tract infections
M L Corrado, M Hesney, W E Struble, et al.
The American Journal of Cardiology
|
September 18, 1990
Expanded clinical evaluation of lovastatin (EXCEL) study: design and patient characteristics of a double-blind, placebo-controlled study in patients with moderate hypercholesterolemia
R H Bradford, C L Shear, A N Chremos, et al.
Archives of Internal Medicine
|
January 1, 1991
Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia
R H Bradford, C L Shear, A N Chremos, et al.
The American Journal of Medicine
|
July 31, 1991
Expanded clinical evaluation of lovastatin (EXCEL) study results: III. Efficacy in modifying lipoproteins and implications for managing patients with moderate hypercholesterolemia
R H Bradford, C L Shear, A N Chremos, et al.
Antimicrobial Agents and Chemotherapy
|
April 4, 1998
Single-dose pharmacokinetics of indinavir and the effect of food
K C Yeh, P J Deutsch, H Haddix, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Clinical Therapeutics
|
January 1, 1985
Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial
G B Calandra, M Hesney, K R Brown
European Journal of Cancer & Clinical Oncology
|
January 1, 1988
The tolerability profile of prophylactic norfloxacin in neutropenic patients
M L Corrado, W E Struble, M Hesney
European Journal of Clinical Microbiology
|
October 1, 1984
A multiclinic randomized study of the comparative efficacy, safety and tolerance of imipenem/cilastatin and moxalactam
G B Calandra, M Hesney, C Grad
Journal of Pharmaceutical Sciences
|
June 1, 1978
Bioequivalence and interchangeability
S Hwang, P B Huber, M Hesney, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
August 5, 2000
Enalapril in RAPIDISC (wafer formulation): pharmacokinetic evaluation of a novel, convenient formulation
Lo M-W, J B McCrea, C R Shadle, et al.
European Urology
|
January 1, 1990
Norfloxacin versus trimethoprim-sulfamethoxazole in the treatment of urinary tract infections
M L Corrado, M Hesney, W E Struble, et al.
The American Journal of Cardiology
|
September 18, 1990
Expanded clinical evaluation of lovastatin (EXCEL) study: design and patient characteristics of a double-blind, placebo-controlled study in patients with moderate hypercholesterolemia
R H Bradford, C L Shear, A N Chremos, et al.
Archives of Internal Medicine
|
January 1, 1991
Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia
R H Bradford, C L Shear, A N Chremos, et al.
The American Journal of Medicine
|
July 31, 1991
Expanded clinical evaluation of lovastatin (EXCEL) study results: III. Efficacy in modifying lipoproteins and implications for managing patients with moderate hypercholesterolemia
R H Bradford, C L Shear, A N Chremos, et al.
Antimicrobial Agents and Chemotherapy
|
April 4, 1998
Single-dose pharmacokinetics of indinavir and the effect of food
K C Yeh, P J Deutsch, H Haddix, et al.
Page
of 2